Cargando…
A Synergetic Screening Approach with Companion Effector for Combination Therapy: Application to Retinoblastoma
For many cancers, the lack of potency and the toxicity of current drugs limits the dose achievable in patients and the efficacy of treatment. Among them, retinoblastoma is a rare cancer of the eye for which better chemotherapeutic options are needed. Combination therapy is a compelling approach to e...
Autores principales: | Mahida, Jeni P., Antczak, Christophe, DeCarlo, Daniel, Champ, Kathryn G., Francis, Jasmine H., Marr, Brian, Polans, Arthur S., Albert, Daniel M., Abramson, David H., Djaballah, Hakim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602587/ https://www.ncbi.nlm.nih.gov/pubmed/23527118 http://dx.doi.org/10.1371/journal.pone.0059156 |
Ejemplares similares
-
Carboplatin +/− Topotecan Ophthalmic Artery Chemosurgery for Intraocular Retinoblastoma
por: Francis, Jasmine H., et al.
Publicado: (2013) -
Death by Water: Precautionary Water Submersion for Intravitreal Injection of Retinoblastoma Eyes
por: Francis, Jasmine H, et al.
Publicado: (2014) -
Combined, Sequential Intravenous and Intra-Arterial Chemotherapy (Bridge Chemotherapy) for Young Infants with Retinoblastoma
por: Gobin, Y. Pierre, et al.
Publicado: (2012) -
Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma
por: Abramson, David H., et al.
Publicado: (2016) -
Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC
por: Abramson, David H., et al.
Publicado: (2015)